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Abstract.  The glycoprotein gp210 is located in the 
"pore membrane," a  specialized domain of the nuclear 
envelope to which the nuclear pore complex (NPC) is 
anchored,  gp210 contains a large cisternal domain,  a 
single transmembrane  segment (TM), and a COOH- 
terminal,  58-amino acid residue cytoplasmic tail (CT) 
(Wozniak,  R. W.,  E.  Bartnik,  and G. Blobel.  1989. J. 
Cell Biol.  108:2083-2092;  Greber,  U.  E,  A.  Senior, 
and L.  Gerace.  1990.  EMBO  (Eur. Mol.  Biol.  Organ.) 
J.  9:1495-1502).  To locate determinants for sorting of 
gp210 to the pore membrane,  we constructed various 
cDNAs coding for wild-type, mutant,  and chimeric 
gp210,  and monitored localization of the expressed 
protein in 3T3 cells by immunofluorescence micros- 
copy using appropriate antibodies.  The large cisternal 
domain of gp210 (95% of its mass) did not reveal any 
sorting determinants.  Surprisingly,  the TM of gp210 is 
sufficient for sorting to the pore membrane.  The CT 
also contains a sorting determinant,  but it is weaker 
than that of the TM. We propose specific lateral asso- 
ciation of the transmembrane helices of two proteins 
to yield either a gp210 homodimer or a heterodimer 
of gp210 and another protein.  The cytoplasmically 
oriented tails of these dimers may bind cooperatively 
to the adjacent NPCs. In addition,  we demonstrate 
that gp210 co-localizes with cytoplasmically dispersed 
nucleoporins,  suggesting a cytoplasmic association of 
these components. 
T 
hE nuclear envelope (NE)  ~  consists of three morpho- 
logically and biochemically distinct  domains (for re- 
view see 9, 12). The outer nuclear membrane domain 
contains bound ribosomes and is continuous with and bio- 
chemically  indistinguishable  from the RER. The inner nu- 
clear membrane domain is adjacent to the nuclear lamina 
and the underlying chromatin,  and contains a distinct set of 
integral membrane proteins (1, 29, 36). Finally, the outer and 
inner membranes of the NE are connected with each other 
at numerous sites forming circular openings in the NE (nu- 
clear pores) of "~100 nm diam.  The connecting  membrane 
is sharply bent (180~  and is referred to as the "pore mem- 
brane" domain of the NE. The nuclear pore is occupied by 
the nuclear pore complex (NPC) and the pore membrane is 
adjacent to the NPC (for review see 9, 21). The pore mem- 
brane contains  at least one distinct glycoprotein,  referred to 
as gp210 (10, 37). This, and perhaps other yet to be identified 
pore membrane-specific integral  proteins,  may function in 
nuclear pore formation  and in the assembly and attachment 
of the NPC to the pore membrane. 
Gp210 has been estimated to be present in 16-24 copies 
per nuclear pore (9). Its primary structure has been deduced 
from overlapping  cDNA clones (37),  and its topology has 
been determined  using proteolytic enzymes and  domain- 
specific antibodies  (11; E. Bartnik,  R. W. Wozniak,  and G. 
1. Abbreviations used in this paper: CT, cytoplasmic  tail; HA, hemagglu- 
tinin; NE, nuclear envelope; NPC, nuclear pore complex;  PCR, polymer- 
ase chain reaction; TM, transmembrane segment. 
Blobel, unpublished  results),  gp210 has an estimated mass 
of'~ 210,000 D, 5 % of which consists of N-linked, high rnan- 
nose-type oligosaccharides (2, 37). The deduced primary 
structure reveals an NH2-terminal,  cleaved signal sequence 
of 25  residues  followed  by  1,861 residues of the mature 
gp210.  The NH~-terminal  1,783 residues of mature gp210 
are exposed on the intracisternal  side of the pore membrane. 
This is followed by a transmembrane segment (TM) of 21 
residues and a COOH-terminal tail of 58 residues.  The tail 
is exposed at the nuclear pore and is therefore a potential an- 
chor for components of the NPC. 
How is gp210 sorted to the pore membrane after its signal- 
and  stop-~ansfer  sequence-mediated integration  into  the 
RER and the outer nuclear membrane? Like resident integral 
proteins of the RER and the NE, gp210 is designed to resist 
bulk flow from the RER into downstream membranes of the 
exocytotic  pathway. In addition,  it is sorted specifically to the 
pore membrane of the NE. Retention in the ER of a number 
of resident integral proteins,  both endogenous and viral, has 
been shown to be mediated by sequences in the cytoplasmi- 
cally exposed domains of these proteins (13, 24, 26).  Be- 
cause of its likely interaction  with the NPC, the cytoplasmi- 
cally exposed tail of gp210 seemed a likely candidate to be 
the determinant  for sorting to the pore membrane. However, 
using various mutant forms of gp210, we found that its TM 
is sufficient for sorting to the pore membrane.  The cytoplas- 
mic tail (CT) serves as an additional,  but weaker, sorting de- 
terminant. 
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Construction of  a Full-Length  gp210 cDNA 
The eDNA sequence of rat gp210 has been previously  determined from a 
series of overlapping, partial eDNA clones (37). To assemble a full-length 
eDNA molecule encoding rat gp210, we used the polymerase chain reaction 
(PCR) to synthesize three independent eDNAs each representing  approxi- 
mately one-third of the 5,658-nucleotide coding region: a 5' fragment (nucleo- 
tides -12-1,997), a middle fragment (nucleotides  1,988-3,854),  and a 3' 
fragment (nucleotides  3,845-5,708).  The templates  used for amplification 
were the partial cDNA clones.  Oligonucleotide  primers were designed on 
the basis of the published eDNA sequence of gp210. 
Synthesis of the 5' fragment was complicated  by the lack of a complete 
template encoding this region. To circumvent this problem, inserts from 
three overlapping,  partial cDNA clones, which together span this region, 
50-17, 45-A1,  and 47-10 07), were used to synthesize a hybrid cDNA of 
sufficient length to act as a template for amplification.  Synthesis of this tem- 
plate was performed as follows. Two overlapping eDNA clones, 50-17 and 
45-A1 ('~50 rig each), were cleaved with EcoRI and XhoI, respectively, to 
liberate two overlapping inserts.  The resulting DNA fragments were com- 
bined and heat denatured at 95~  for 10 min in lx Taq polymerase buffer 
(Perkin-Elmer Cetus Instruments, Norwalk, CT). The denatured DNA was 
allowed to reanneai at 65~  for 30 rain and dATP, dCTP, dGTP, and dTTP 
were added to a final concentration of 0.2 mM each. The reaction tempera- 
ture was raised to 72~  and 2.5 U ofTaq polymerase (Perkin Elmer Cetus 
Instruments) was added to fill in the fraction of DNA molecules formed by 
the hybridization of overlapping single-stranded inserts from 50-17 and 
45-A1. The polymerization was allowed to proceed for 8 rain at 72~  The 
DNA from this reaction, containing the double-stranded 50-17/45-A1  hy- 
brid, was combined with ~50 ng of EcoRI/AatlI cut 47-10 eDNA, and the 
denaturation, annealing,  and polymerization steps repeated  as above to 
form a  50-17/45-A1/47-10  hybrid eDNA.  Although this species  likely 
represents  only a  fraction of the total eDNA present in the reaction, it 
proved  sufficient  for amplification.  With this template,  a  PCR was per- 
formed using a sense oligonucleotide  encoding a 5' SalI site followed by 
nucleotides  -12-33 (sense primer) and an antisense  oligonucleotide  encod- 
ing nucleotides  1,967-1,997 (antisense primer). 
Two additional PCR products were synthesized encoding the remaining 
two-thirds of the full-length eDNA. The middle segment was synthesized 
using the eDNA clone 47-11 as a template and oligonucleotide  primers en- 
coding  nucleotides  1,937-2,016  (sense)  and nucleotides  3,826-3,854  (an- 
tisense).  The 3' segment was synthesized using the eDNA clone 49-10 as 
a template and oligonucleotide  primers encoding nucleotides  3,845-3,873 
(sense) and nucleotides 5,664-5,708 plus a 5' SalI site (antisense).  Point mu- 
tations were introduced at nucleotide positions 1,992 and 3,849 of the above 
oligonucleotide primers to create two unique BstBI sites at positions 1,990 
and 3,847 without altering the amino acid sequence of gp210. These sites 
were used to assemble a full-length gp210 eDNA with flanking, unique SaiI 
sites. Sequencing of this clone revealed four nucleotide changes produced 
during the PCR reactions.  Two of these led to changes in the amino acid 
sequence,  one at position 491 (serine to glycine) and the other at position 
1,131 (leucine to histidine). 
Epitope Tagging of  gp210 
To distinguish the expression of recombinant gp210 from the endogenous 
protein, an epitope tag encoding a 12-amino acid residue peptide from the 
influenza virus HA molecule (8, 34), with two flanking glycine residues 
added as spacers, was inserted into gp210 after amino acid residue 28. This 
was accomplished by synthesizing  two complimentary oligonucleotides, 
HA-1 and HA-2,  with the following sequence. 
5' ag cta ggt  tac cca tac 8at  gtt  cca gat tac  get age ttg  ggt  a 3'  HA-1 
3' t  cca atg ggt  atg cta  caa ggt  cta  atg cga tcg  aac cca ttc  ga 5'  HA-2 
G  Y  P  Y  O  V  P  D  Y  A  S  L  G  amino acid 
res i dues 
This oligonucleotide pair was inserted into a HindIII site (nucleotide 79) 
of the gp210 eDNA.  The orientation of the insert and the reading frame of 
the resulting  gp210:HA eDNA was confirmed by DNA sequencing.  The 
gp210:HA eDNA was subcloned into the XhoI site of the eukaryotic expres- 
sion vector pSVL (Pharmacia LKB Biotechnology,  Piscataway, NJ). 
Construction of the gp210-(TM + CT):HA 
Deletion Mutant 
Deletion of the TM and the CT of gp210 was achieved by inserting a stop 
codon after nucleotide 5,424 into the gp210:HA cDNA. This was accom- 
plished by inserting a PCR product into a unique BgllI site at nucleotide 
5,139. This PCR product is identical to the gp210 eDNA from the BglH site 
downstream to the codon for amino acid residue  1,808, after which a stop 
eodon is inserted. It was synthesized using the eDNA clone 49-10 as a tem- 
plate and two oligonucleotide primers, a sense primer encoding nucleotides 
5,125-5,141 and an antisense primer encoding nncleotides 5,409-5,424 fol- 
lowed by an in-frame stop codon and a 5' BglII linker. After cleavage with 
BglII, the PCR product was introduced into the gp210:HA reading frame 
at the BgllI site. The orientation and the reading frame of the insert were 
determined by DNA sequencing.  This gp210-(TM +  CT):HA mutant (see 
Fig.  1) was inserted into the pSVL plasmid for expression studies. 
Construction of  Expression Plasmids Containing 
CD8 and CD8/gp210 Chimeric cDNAs 
Expression of the wild-type CD8 eDNA was accomplished as follows. A 
pSP65  plasmid containing the F1 eDNA clone of CD8 (18) (pSP65F1, 
kindly provided by Dr. Giovanni Migliaccio, Istituto di Ricerehe di Biologia 
Molecolare,  Pomezia,  Italy) was digested with EcoRI to remove the full- 
length CD8 eDNA. The cohesive ends were filled in with Klenow fragment 
and the eDNA was subeloned into the Sinai site of the pSVL plasmid for 
expression  studies. 
Chimeric cDNAs encoding the fusion proteins CD8/gp(TM  +  CT), 
CDS/gp(TM  +  CT)-20, and CDS/gp(TM  +  CT)-54 (see Fig.  1) were con- 
structed as follows, pSP65FI was digested with XbaI and EcoRV to produce 
a DNA fragment containing nucleotides  1-611 of the CD8 eDNA (18). The 
3' blunt-end site created by EcoRV follows the codon for amino acid residue 
161 (18). This fragment was combined separately with each of three PCR 
products that encode amino acid residues  1,806-1,886 (CDS/gp[TM  + 
CT]), 1,806-1,866 (CDSIgp[TM  +  CT]-20), or 1,806-1,822 (CDS/gp[TM 
+  CT]-54) of gp210 (see Fig.  1). In each PCR product the gp210 coding 
region is followed by a 3' termination codon and a BamHI linker. The CD8 
eDNA fragment was blunt-end ligated to each of the PCR products to pro- 
duce the appropriate chimeric eDNA and subeloned into a Xbal and BamHI 
cut pSVL plasmid. 
The assembly of the CDS/gpCT  and CDS/gpCT-20 chimeric constructs 
(see Fig.  1) was performed by similar methods with the following excep- 
tions. The CD8 portion of the molecule was contributed by a PCR product 
that begins at a XbaI site in pSP65FI upstream of the CD8 eDNA and con- 
tinues through CD8 to nucleotide 692.  The PCR product encoding the 
gp210 CT and the 20-amino acid deletion both begin with nucleotide 5,485 
and end with a termination codon and a BamHl linker aRer nucleotide 5,664 
(CDS/gpCT)  or nueleotide 5,598  (CDg/gpCT-20).  The PCR product de- 
rived from the CD8 eDNA was blunt-end ligated to each of the gp210 PCR 
products to produce the appropriate chimeric eDNAs which were subcloned 
using their flanking XbaI and BamHI sites into the pSVL expression plas- 
mid. The structure of all of the above mutants was confirmed by DNA se- 
quencing. The CDS/EI9 chimeric eDNA within the pCMU1V plasmid (24) 
was kindly provided by Dr. Stefano Bonatti (Universiflt di Napoli, Napoli, 
Italy) with permission from Dr. Per Peterson (Scripps Clinic, La Jolla, CA). 
Expression of  Recombinant cDNAs in Mouse Balb/c 
3T3 l~broblasts 
The expression of chimeric proteins in mouse Baib/c 3T3 cells was accom- 
plished by direct microinjection of plasmid DNA into nuclei using a proce- 
dure described by Capecchi (5). Subconfiuent cultures of Baibtc 3T3 cells 
wore grown on 12-ram diam. glass coverslips in DME medium (Gibco Lab- 
oratories, Grand Island, NY) supplemented with 10% FBS (Gibco Labora- 
tories), 20 mM Hepes, pH 7.4, and 50 ~g/mi Gentamycin (Gibco Laborato- 
ries). Nuclei were injected with plasmid DNA purified using a plasmid 
purification kit (Qingen Inc., Chatsworth, CA) at 1 mg/ml in PBS containing 
1 mM MgC12. The microinjection equipment consisted of an Eppendorf 
injector 5,242 and a Zeiss micromanipulator MR mounted on a Zeiss Ax- 
iovert 10 microscope  (Zeiss,  Oberkochen, Germany). After injection, the 
cells were returned to a 5% CO2 incubator at 37~  for 4-5 h. 
lmmunofluorescence Microscopy 
Coverslips containing injected 3T3 cells were processed for immunofluores- 
The Journal of Cell Biology, Volume 119, 1992  1442 cence microscopy as follows. 4-5 h after injection, cells were fixed with 
3 % paraformaldehyde in PBS for 20 min on ice. After fixation, cells were 
washed with PBS and permeabilized with 0.1%  Triton X-100  in PBS for 
2  min on ice.  Cells were then washed with PBS  and nonspecitic sites 
blocked with milk buffer (2%  nonfat dry milk, 0.1%  Tween 20,  40 mM 
K2HPO,,,  10 mM KI-I2PO4, 150 mM NaCI, and 0.01% NAN3) for 1-2 h at 
room temperature. All subsequent steps were performed at room tempera- 
ture. First antibody incubations to detect epitope-tagged proteins were per- 
formed with an mAb,  12C.A5 0dndly provided by Dr.  Richard Lerner, 
Scripps Clinic, La Jolla, CA), specific for the HA peptide tag (34) (at a 
1:300 dilution of ascites fluid in 1% BSA in PBS). The detection of wild- 
type CD8 and CD8-eontaining chimeric proteins was performed with an 
mAb,  OKT8  (kindly  provided by  Dr.  Giovanni  Migliaccio,  Istituto  di 
Ricerche di Biologia Molecolare, Pomezia, Italy), directed against the ex- 
tracellular domain of CD8 (at a 1:100 dilution of culture supematant in milk 
buffer). First antibody incubations were performed for 40 min followed by 
extensive washing with milk buffer. Primary antibody reactivity was visual- 
ized with Texas red-conjugated goat anti-mouse IgG (Molecular Probes, 
Inc., Eugene OR) used at 10 tzg/ml in milk buffer.  Cells were probed for 
40  min and then washed extensively with milk buffer followed by two 
washes with 1% BSA in PBS. 
For  double-immunofluorescence experiments with  the  NPC-specific 
mAb 414 (7), the expressed recombinant protein was first detected with pri- 
mary and secondary antibodies as described above and then processed as 
follows. Ceils were washed with PBS, refixed with 1% paraforrnaldehyde 
in PBS for 1 min, and washed extensively with PBS. Samples were then 
washed once with milk buffer and incubated for 15 min with a 1:50 dilution 
of mouse serum in milk buffer to block nonspecific sites. After this incuba- 
tion, cells were probed for 30 rain with FITC-labeled mAb 414 (kindly 
provided by Dr. Thomas Meier, Rockefeller University, New York, NY) in 
milk buffer containing a 1:100 dilution of mouse serum. Unbound antibody 
was removed by extensive washing with milk buffer followed by two washes 
with 1% BSA in PBS. For all immunofluorescence experiments, cells were 
mounted in 90%  glycerol containing  1 mg/ml p-phenylenediamine and 
viewed with a Zeiss Axiophot microscope. Photographs were taken through 
a 63x  or 100x  objective onto Kodak (T-Max 400,  Eastman Kodak Co., 
Rochester, NY) film push processed to  1600  ASA. 
GP210:HA  F..~ 
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Results 
After its integration into the ER membrane, gp210 is sorted 
to the pore membrane, most likely by lateral diffusion in the 
plane of the membrane. To locate the determinant(s) for sort- 
ing,  we constructed various cDNAs coding for wild-type, 
mutant, and chimeric gp210 (Fig.  1);  subcloned them into 
a transient eukaryotic expression vector (pSVL); injected the 
DNA directly into the nuclei  of subconfluent,  unsynchro- 
nized 3T3 cells; and monitored localization of the expressed 
protein by immunofluorescence microscopy using the appro- 
priate antibodies. Typically, 100-200 cells were injected for 
each experiment and the location of expressed protein was 
assessed 4-5  h  after injection.  This  time period  was  ex- 
perimentally determined to be optimal as it yielded levels of 
expressed protein that were  sufficient for immunofluores- 
cence detection but avoided overexpression and concomitant 
mislocalization. 
Epitope-tagged gp210:HA Is Sorted 
to the Pore Membrane 
To distinguish the expression of recombinant from endoge- 
nous gp210, we inserted an epitope tag encoding 12-amino 
acid residues of HA (8,  34) after the second residue of the 
mature form of gp210 (see Fig.  1).  Using an mAb against 
the tag (anti-HA antibody), the expressed gp210:HA showed 
the punctate distribution at the nuclear surface (Fig. 2 A) that 
is characteristic for endogenous gp210 in the pore membrane 
(6). To further substantiate the localization of gp210:HA in 
GCD8/gp(TM+CT)-20 
N  c 
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Figure 1. Schematic representations of eDNA constructs.  The terms used for each construct are shown on the left. The amino terminus 
(N) and the carboxy terminus (C) are indicated.  Segments positioned to the left of the schematic lipid bilayer lie within the lumenal or 
extracellular compartments and those to the right extend into the cytosol. Amino acid residues within regions of interest are listed below 
each schematic diagram.  Those residues that span the membrane are underlined.  Regions of the constructs derived from gp210 or CD8 
are distinguished graphically and by print type (gp210 ~  or CD8 m).  Amino acid residues are numbered in accordance with publica- 
tions describing their positions within the wild-type proteins (18, 37). The arrowheads in gp210:HA and gp210-(TM  +  CT):HA point 
to the approximate position of the HA epitope  tag. 
Wozniak  and Blobel Sorting of gp210 to the Nuclear Pore Membrane  1443 Figure 2. gp210:HA is targeted to the pore membrane domain. Cells expressing the epitope-tagged gp210:HA protein (see Fig. 1) were 
fixed, permeabilized, and probed with an mAb (12CA5) directed against the HA epitope tag. Binding to gp210:HA was visualized with 
Texas red-labeled goat anti-mouse IgG (mAb  anti-HA, A). The locations of  pore complexes within the same cell were determined by probing 
with a FITC-labeled mAb specific for a subset of the nucleoporins (mAb 414, B). The focal plane shown in A and B is tangential to the 
nuclear surface, gp210:HA is visible at densely packed points along the surface of the nucleus and, to a much lesser extent, in a dispersed 
pattern in the cytoplasm. Note the extensive coincidence between this pattern and the NPC pattern shown in B. Bar, 10 #m. 
the pore membrane, we carried out double immunofluores- 
cence with mAb 414 (Fig. 2 B). This mAb reacts with sev- 
eral nucleoporins (7) (all proteins of the NPC, excluding in- 
tegral proteins of the pore membrane). A comparison of the 
two staining patterns (Fig. 2, A and B) showed considerable 
congruity, not only between the densely punctate pattern at 
the nuclear surface, but also between the more dispersed 
punctate pattern observed in the cytoplasm. The matching 
patterns in the cytoplasm suggest that gp210:HA and at least 
some of the nucleoporins are present as assembled structures 
in the ER.  These structures might be similar to annulate 
lamellae (15).  Together these data suggest that epitope tag- 
ging of gp210 does not interfere with sorting. 
Gp210:HA Lacking the TM and the CT Is Not Sorted 
to the Pore Membrane 
Having shown that gp210:HA is correctly sorted, we con- 
structed a mutant cDNA coding for a protein that lacked both 
the TM and the CT, referred to as gp210-(TM  +  CT):HA 
(see Fig. 1). This protein showed a distribution characteristic 
of ER proteins (Fig. 3 B) and was no longer visible in the 
pore membrane, either when focusing on the nuclear surface 
(not shown), or when focusing on the nuclear rim (Fig. 3 B). 
Double immunofluorescence with mAb 414 did show the 
characteristic punctate rim pattern of the nucleoporins (Fig. 
3 A). Likewise, a punctate nuclear rim staining pattern was 
seen with the anti-HA antibody in ceils expressing gp210:HA 
(Fig. 3 C). We conclude that the NH2-terminal ectoplasmic 
domain preceding the TM and comprising "~95%  of gp210 
lacks topogenic determinants for sorting to the pore mem- 
brane. 
The TM of  gp210 Is SuJ~cient for Sorting 
to the Pore Membrane 
As the NH2-terminal ectoplasmic domain of gp210 is  not 
localized to the pore membrane, the topogenic determinants 
for pore membrane localization of gp210 must reside either 
in its TM, or in its CT, or in both. To distinguish between 
these possibilities, we constructed a eDNA coding for a chi- 
meric protein, referred to as CD8/gp(TM  +  CT) (see Fig. 
1) that consists of the ectoplasmic domain of CD8, used as 
a reporter, and the TM plus the CT of gp210. CD8 is an inte- 
gral protein of the plasma membrane present in a subset of 
human T  lymphocytes (27). Like gp210, CD8 is a bitopic 
integral membrane protein.  Its  NH2-terminal ectoplasmic 
domain (161 residues) is followed by a TM and a CT (28 resi- 
dues)  (18, 31).  After  signal-  and  stop-transfer  sequence- 
mediated integration into the RER,  CD8 ends up,  via the 
exocytotic pathway, in the plasma membrane. If the TM and 
the CT (TM  +  CT) portions of gp210 contain the deter- 
minants for sorting to the pore membrane, the chimera CD8/ 
gp(TM  +  CT) should be localized to the pore membrane. 
Indeed, staining of cells expressing this fusion protein with 
an anti-CD8 antibody showed a characteristic punctate pore 
The Jouroa] of Cell Biology,  Volume 119, 1992  1444 Figure 3. The targeting of gp210:HA to the pore membrane is dependent on the presence of the TM and the CT. Cells expressing the 
gp210-(TM + CT):HA mutant (see Fig. 1) were examined using the double-immunofluorescence  procedure described in Fig. 2 to compare 
the localization of  this chimeric protein (mAb anti-HA, B) to the position of  pore complexes (mAb 414, A). For comparison, a cell expressing 
gp210:HA is shown in C. In each case, the focal plane passes through the center of the nucleus and reveals the nuclear rim. In this focal 
plane, pore complexes are visible as a punctate ring around the nucleus (A). Note the presence of the gp210-(TM +  CT):HA protein 
in the ER (B) and compared this with the positions of pore complexes (A) and the contrasting pattern seen for gp210:HA (C). Bar, 10/~m. 
membrane pattern at the nuclear surface and at distinct points 
in the cytoplasm (Fig. 4 A).  This pattern was largely con- 
gruent with that obtained with mAb 414 (Fig. 4 C) in doubly 
stained cells. A control experiment showed wild-type CD8 
to localize to the plasma membrane (Fig. 4 B). 
To determine whether the CT domain of CD8/gp(TM  + 
CT) is  required for sorting,  we prepared a  series of con- 
structs where 10, 20,  30,  43,  and 54 COOH-terminal resi- 
dues of the 58-residue-long CT of the CD8/gp(TM  +  CT) 
were deleted (see Fig. 1). All of  these proteins were correctly 
sorted  to  the  pore  membrane.  Only  the  data  for  the 
CD8/gp(TM  +  CT)-20  and  CD8/gp(TM  +  CT)-54  are 
shown (Fig. 5). Double immunofluorescence with both the 
anti-CD8 antibody and mAb 414 showed that the distribution 
of these chimeric proteins (Fig. 5 A and B) matched that of 
the nucleoporins (Fig. 5, C and D). The 54-residue deletion 
removes nearly the entire CT leaving only four residues of 
the CT adjacent to the lipid bilayer. Data presented in the 
next section demonstrate that these four remaining residues 
are not sufficient for targeting to the pore membrane within 
the context of  the CD8 TM (see Fig. 7 B). Therefore, at most 
they play an accessory role in sorting. We thus conclude that 
the  TM  of gp210  is  sufficient for pore membrane local- 
ization. 
The CT of  gp210 Is a Sufficient, 
but Weak, Determinant for Sorting 
to the Pore Membrane 
To examine whether the CT of gp210 by itself contains topo- 
genic determinants for pore membrane localization, we pre- 
pared a chimeric construct referred to as CD8/gpCT, where 
the CT of CD8 was replaced with that of gp210 (see Fig. 1). 
Immunofluorescence with anti-CD8 antibody (Fig. 6 B) de- 
tected CD8/gpCT at the plasma  membrane,  in  a  densely 
stained region near the nucleus (presumably representing the 
Golgi complex), and in a punctate pattern along the nuclear 
rim. This punctate nuclear rim pattern of CDS/gpCT matched 
the nucleoporin pattern when cells were double stained with 
mAb 414 (Fig. 6 A). However, the match was less than per- 
fect, apparently obscured by the Golgi and plasma  mem- 
brane localization of CD8/gpCT.  Additional support for a 
pore membrane localization of CD8/gpCT was provided by 
comparing its staining pattern with that of CD8/E19, a resi- 
dent integral membrane protein of the ER (13, 24, and Fig. 
6 C). CD8/E19 is a chimeric protein where the CT of CD8 
has been replaced by the CT of El9, a viral protein that is 
retained in the ER (30).  Although both chimeric proteins 
showed  nuclear  rim  staining,  only CD8/E19  additionally 
showed the typical ER staining pattern, indicating that the 
nuclear rim staining of CD8/gpCT is likely the result of lo- 
caiization to the pore membrane, rather than retention in the 
ER. Moreover, a deletion mutant of CD8/gpCT lacking 20 
COOH-terminal residues from the CT (CD8/gpCT-20, see 
Fig.  1)  is  no longer localized to the pore membrane,  but 
rather is present exclusively at the plasma membrane (Fig. 
7, compare A and B). Taken together, these data suggest that 
the CT of gp210 contains a determinant for sorting to the 
pore membrane and that this determinant might reside in its 
COOH-terminal 20 residues. 
Discussion 
Most integral proteins of the membranes in the exo- and en- 
docytotic pathway are asymmetrically integrated into the ER 
Wozniak and Blobel  Sorting of gp210 to the Nuclear Pore Membrane  1445 Figure 4. A reporter protein can be targeted to the pore membrane by the TM and the CT of gp210. 3T3 cells expressing the chimeric 
protein CD8/gp(TM  +  CT) (see Fig. 1), were examined by double immunofluorescence microscopy. Cells were fixed, permeabilized, 
and probed with an mAb, OKT8, directed against the extracellular domain of CD8 (mAb anti-CD8; A). Binding of anti-CD8 antibody 
was determined with Texas red-labeled goat anti-mouse IgG. Two cells expressing the CD81gp(TM +  CT) chimera are shown in A. The 
focal plane is positioned to show the nuclear surface of one cell and the nuclear rim of the other. The locations of pore complexes within 
the same ceils were identified using FITC-labeled mAb 414 (C). Those cells not expressing the chimeric protein are recognized only by 
mAb 414. Note the extensive coincidental staining at the nuclear surface and in the cytoplasm when comparing A and C. For comparison, 
the cell-surface expression of wild-type CD8 in 3T3 cells is shown in B. Bar, 10/~m. 
by signal- and stop-transfer sequence-mediated mechanisms 
(14,  17).  After integration into the ER membrane, sorting 
determinants  specify retention within  the  ER  or  various 
downstream membranes of the exo- and endocytotic path- 
ways (3). For the few examples of resident integral ER pro- 
teins that have so far been examined, COOH-terminal and, 
generally,  cytoplasmically  exposed  regions,  have  been 
shown to be sorting determinants for their retention in the 
ER (13, 24, 26, 32). In this paper we have analyzed deter- 
minants that sort gp210 to a subdomain of the ER, the pore 
membrane domain of the NE. As the pore membrane is con- 
tinuous with the ER, sorting to this domain is likely to pro- 
ceed by lateral diffusion in the plane of the membrane rather 
than by vesicular traffic, gp210 is a bitopic integral mem- 
brane protein with a  large NH2-terminal cisternal domain 
(1,783 residues), a single TM, and a short COOH-terminal 
CT of 58 residues. The latter is topologically poised to inter- 
act with the NPC and a priori appeared to be the most likely 
candidate to harbor the determinant for sorting to the pore 
membrane. Surprisingly, we found that the TM of gp210 is 
sufficient for sorting to the pore membrane.  Although the 
CT, particularly its COOH-terminal 20 residues, also con- 
tained a determinant for sorting to the pore membrane, the 
TM appeared to be the dominant sorting determinant. By it- 
self, it was sufficient for sorting to the pore membrane. The 
ectoplasmic domain of gp210 that contributes 95%  of its 
mass does not appear to contain determinants for sorting to 
the pore membrane. It appears to be retained in the ER, but 
our data do not rule out secretion. 
In thinking about possible mechanisms by which the TM 
of gp210 could function as a dominant sorting determinant, 
one should consider the following uncertainties.  First, the 
gp210  mutants  studied  here were expressed in  ceils  that 
make their own "endogenous"  gp210. We do not know the ra- 
tio  of expressed (mutant)  versus endogenous (wild-type) 
gp210 in individual pores. Second, although nuclear pores 
are doubled in $  phase (22), mutant gp210 expression, over 
a period of 5 h, was assayed in unsynchronized, interphase 
cells. Thus, expressed mutant gp210 may have been involved 
in de novo formation of pores and/or may have gained ac- 
The Journal of Cell Biology,  Volume 119, 1992  1446 Figure 5. Targeting  to the pore membrane of the CD8/gp(TM + CT) fusion protein is unaffected  by deletions of  the CT. 3T3 cells expressing 
the COOH-terminal deletion mutant CD8/gp(TM +  CT)-20 or CD8/gp(TM  +  CT)-54 (see Fig. 1) were examined using the procedure 
described in Fig. 4 to visualize the chimeric proteins (mAb anti-CD8; A and B) and the pore complexes (mAb 414; C and D). All cells 
are recognized by mAb 414(C and D), whereas only those expressing the chimeric proteins are detected with the anti-CD8 antibody (A 
and B). Bar, 10 #m. 
cess to already formed pores by exchange with endogenous 
gp210. It should be noted that at present little is known about 
the dynamics of pore formation and NPC assembly or the 
stability of the interacting components. Whether involved in 
de novo formation of  pores or in lateral exchange, we suggest 
that gp210's  TM functions as the dominant sorting deter- 
minant because of the specific surface features of the a-helix 
that it forms. These features would allow specific lateral in- 
teractions with another transmembrane  a-helix,  either of 
gp210  or  another  integral  membrane protein,  to  form a 
homodimer or heterodimer, respectively. 
That lateral interactions between a-helices of TMs of inte- 
gral  membrane proteins can be specific was  first demon- 
strated for the dimer of  human erythrocyte  glycophorin A (4, 
16). Disruption of  the dimer can be accomplished with a syn- 
thetic peptide representing the TM of glycophorin A but not 
with similar peptides representing the TMs of other integral 
membrane proteins (4,  16).  Limited mutational analysis of 
this interaction suggests that close packing of side chains at 
the interface of adjacent helices may be required for dimer- 
ization (for a review of other examples of specific interac- 
tions via transmembrane helices see reference 16). 
The TM of gp210 does not contain charged residues; thus, 
dimerization stabilized by charged ion pairs can be ruled out. 
It is noteworthy that the aromatic residues, two tyrosines and 
four phenylalanines, are arranged on one face of the mem- 
brane helix, with five of the six aromatic residues located on 
the  NH2-terminal  half of the  a-helix  embedded  into  the 
cisternal leaflet of  the pore membrane bilayer. Whether these 
or other features of the gp210 transmembrane a-helix allow 
specific  lateral  interactions  with  another  transmembrane 
a-helix remains to be investigated. 
There are precedents for TMs serving as topogenic deter- 
minants. Most resident integral proteins of the Golgi mem- 
brane that have so far been analyzed are retained there by 
sorting determinants in their TMs (20, 23, 25, 28, 33, 35, for 
review see 19). 
The sorting determinants in gp210's CT, albeit apparently 
weaker than those of the TM, are likely to be relevant. If 
gp210 were to form homodimers via the TM, this could spa- 
Wozniak and Blobel Sorting of gp210 to the Nuclear Pore Membrane  1447 Figure 6. The CT of gp210 also contains a pore membrane targeting signal. The chimeric protein CD8/gpCT (see Fig. 1) was expressed 
in 3T3 cells and double immunofluorescence was performed, as described  in Fig. 4, to visualize the chimeric protein  (mAb anti-CD8, 
B) and pore complexes (mAb 414, A). Also shown is the distribution pattern of the CDg/E19 chimeric protein within a separate cell (C). 
In all eases, the focal plane shown passes through the center of the nucleus. In focus are the nuclear rim, adjacent regions of the cytoplasm, 
and portions of the plasma membrane. Note the presence of CD8/gpCT  (B) at the cell surface as well as at the NE in a pattern similar 
to that revealed with mAb 414 (A). This distribution is compared to the CDg/E19 protein which is retained within the ER network and 
the NE (C). Bar,  10 tan. 
tially orient the two CTs and give rise to cooperative binding 
effects to the NPC of significantly higher avidity than would 
be observed with a single CT alone. If gp210 were to form 
a heterodimer, a high affinity for the NPC of the CT of its 
heterodimeric partner could likewise result in cooperative 
binding effects of gp210's CT. 
Our observation that a fraction of gp210 co-localizes with 
the eytoplasmically dispersed, mAb 414-reactive nucleopo- 
rins suggests that these components are associated with each 
other,  perhaps in  annulate  lamellae.  These structures  are 
likely to represent excess pore membrane and pore complex 
components. Mutant gp210 appeared to be sorted to these 
Figure 7. A 20-amino acid residue deletion from the COOH-terminal  tail of the CD8/gpCT chimera abolishes NE localization. 3T3 cells 
expressing CD8/gpCT (A) or the deletion mutant CD8/gpCT-20 (B) were fixed, permeabilized, and probed with anti-CD8 antibody. Binding 
was visualized with Texas red-labeled goat anti-mouse IgG. The focal plane shown reveals the cell surface adjacent to the coverslip. Note 
that both chimeric proteins are visible at the cell surface (A and B), but the punctate  NE staining pattern  seen with CD8/gpCT  (A) is 
absent in the CD8/gpCT-20 expressing cell (B). Bar,  10 #m. 
The Journal of Cell Biology. Volume 119. 1992  1448 cytoplasmic structures as long as they are also sorted to the 
pore membrane domain of the NE (see Figs. 2, 4, and 5). 
It therefore seems likely that sorting of gp210 to a pore mem- 
brane domain in the ER occurs by the same principles as 
sorting to the pore membrane domain of the NE. 
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